These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10083400)

  • 21. Human complement regulatory proteins expressed in transgenic swine protect swine xenografts from humoral injury.
    McCurry KR; Diamond LE; Kooyman DL; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1996 Apr; 28(2):758. PubMed ID: 8623384
    [No Abstract]   [Full Text] [Related]  

  • 22. Sequential immunohistological analysis of porcine grafts in cynomolgus recipients after discordant kidney xenotransplantation.
    Schmidtko J; Loss M; Kilic E; Kunz R; Deiwick A; Metz-Rensing K; Kaup F; Klempnauer J; Helmchen U; Winkler M
    Transplant Proc; 2001; 33(1-2):783. PubMed ID: 11267069
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic engineering of endothelial cells to ameliorate xenograft rejection.
    Bach FH; Robson SC; Wrighton CJ; Stuhlmeier K; Ferran C; Winkler H
    Clin Transplant; 1996 Feb; 10(1 Pt 2):124-7. PubMed ID: 8680048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial cell proteoglycans in xenotransplantation.
    Platt JL; Dalmasso AP; Vercellotti GM; Lindman BJ; Turman MA; Bach FH
    Transplant Proc; 1990 Jun; 22(3):1066. PubMed ID: 2349664
    [No Abstract]   [Full Text] [Related]  

  • 25. Barriers to xenotransplantation.
    Bach FH; Robson SC; Winkler H; Ferran C; Stuhlmeier KM; Wrighton CJ; Hancock WW
    Nat Med; 1995 Sep; 1(9):869-73. PubMed ID: 7585204
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential mechanism of abnormal thromboregulation in xenograft rejection: loss of ecto-ATPases upon endothelial cell activation.
    Robson SC; Candinas D; Siegel JB; Kopp C; Millan M; Hancock WW; Bach FH
    Transplant Proc; 1996 Apr; 28(2):536. PubMed ID: 8623252
    [No Abstract]   [Full Text] [Related]  

  • 27. Activation of endothelial cells in hyperacute xenograft rejection.
    Geller RL; Bach FH; Vercellotti GM; Nistler RS; Bolman RM; Fischel RJ; Leventhal J; Platt JL
    Transplant Proc; 1992 Apr; 24(2):592. PubMed ID: 1566442
    [No Abstract]   [Full Text] [Related]  

  • 28. Some problems related to discordant xenografting.
    Bach FH
    Transplant Proc; 1997 Nov; 29(7):3009-10. PubMed ID: 9365646
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of activated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft.
    Elsen M; Soares M; Latinne D; Cornet A; Bazin H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):447-9. PubMed ID: 8438373
    [No Abstract]   [Full Text] [Related]  

  • 30. Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival.
    Fischel RJ; Bolman RM; Platt JL; Najarian JS; Bach FH; Matas AJ
    Transplant Proc; 1990 Jun; 22(3):1077-8. PubMed ID: 2190373
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of macrophages in endothelial cell injury--a possible mechanism for delayed xenograft rejection.
    Fryer JP; Chen S; Johnson EM; Simone P; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):626. PubMed ID: 8623310
    [No Abstract]   [Full Text] [Related]  

  • 32. Alive and kicking: endothelium at the geographic nexus of vascular rejection.
    Mazer SP; Pinsky DJ
    Circ Res; 2002 Dec; 91(12):1085-8. PubMed ID: 12480807
    [No Abstract]   [Full Text] [Related]  

  • 33. Xenotransplantation: problems and approaches.
    Millan MT; Ferran C; Winkler H; Blakely ML; van der Werf WJ; Hancock WW; Bach FH
    Transplant Proc; 1994 Dec; 26(6):3593-6. PubMed ID: 7998285
    [No Abstract]   [Full Text] [Related]  

  • 34. Xenograft rejection--molecular mechanisms and therapeutic implications.
    Magee JC; Platt JL
    Ther Immunol; 1994 Jan; 1(1):45-58. PubMed ID: 7584479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endothelial cell: an obstacle to xenografting.
    Bach FH
    Pathol Biol (Paris); 1994 Mar; 42(3):213-6. PubMed ID: 8090568
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
    Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
    Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrasplenic preconditioning: a model for the study of xenostimuli accommodation.
    Telpner R; Ben-Abraham R; Klein Y; Nakache R; Khoury W; Weinbroum AA
    J Surg Res; 2011 Jun; 168(1):135-42. PubMed ID: 20080251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement- and xenoantibody-independent discordant xenograft rejection in a guinea pig to rat model.
    Ji P; Xia GL; Waer M
    Transplant Proc; 2000 Aug; 32(5):935. PubMed ID: 10936281
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
    Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
    Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation.
    Richards AC; Davies HF; McLaughlin ML; Copeman LS; Holmes BJ; Dos Santos Cruz G; Bycroft S; Chavez G; White DJ; Schuurman HJ; Cozzi E
    Transplantation; 2002 Mar; 73(6):881-9. PubMed ID: 11923687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.